Advertisement
Heart, Lung and Circulation

Cardiac Surgery in Patients With Blood Disorders

Published:October 20, 2021DOI:https://doi.org/10.1016/j.hlc.2021.09.013
      Blood disorders that can contribute to abnormal bleeding can have a detrimental effect during cardiac surgery. Patients who are known to have such pathologies should be investigated thoroughly and cautious measures would need to be taken when cardiac surgery is needed in this cohort. The majority of current literature for cardiac surgery in patients with von Willebrand Disease and haemophilia are case reports. Nevertheless, evidence shows that optimising factor levels pre, intra and postoperatively offers outcomes similar to that of patients without these disorders. Preoperative screening followed by appropriate iron therapy reduces mortality for patients with anaemia. In this group, haemoglobin levels can be improved postoperatively through iron supplementation. The management strategy of cardiac surgery for people with blood disorders requires a multidisciplinary approach that is highly individualised for each patient. It is essential to adequately adjust preoperative, perioperative and postoperative care to the patient’s blood disorder in order to achieve outcomes similar to that of patients without blood disorders.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Heart, Lung and Circulation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Klein A.
        • Collier T.
        • Brar S.
        • Evans C.
        • Hallward G.
        • Fletcher S.
        The incidence and importance of anaemia in patients undergoing cardiac surgery in the UK – the first Association of Cardiothoracic Anaesthetists national audit.
        Anaesthesia. 2016; 71
        • Musallam K.M.
        • Tamim H.M.
        • Richards T.
        • Spahn D.R.
        • Rosendaal F.R.
        • Habbal A.
        • et al.
        Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study.
        Lancet. 2011; 378: 1396-1407
        • Wahba A.
        • Videm V.
        Heart surgery with extracorporeal circulation leads to platelet activation at the time of hospital discharge.
        Eur J Cardiothorac Surg. 2003; 23: 1046-1050
        • Šrámek A.
        • Reiber J.H.C.
        • Gerrits W.B.J.
        • Rosendaal F.R.
        Decreased coagulability has no clinically relevant effect on atherogenesis.
        Circulation. 2001; 104: 762-767
        • Nichols W.L.
        • Hultin M.B.
        • James A.H.
        • Manco-Johnson M.J.
        • Montgomery R.R.
        • Ortel T.L.
        • et al.
        von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).
        Haemophilia. 2008; 14: 171-232
        • Sadler J.E.
        Biochemistry and genetics of von Willebrand factor.
        Annu Rev Biochem. 1998; 67: 395-424
        • Michiels J.J.
        • Berneman Z.
        • Gadisseur A.
        • van der Planken M.
        • Schroyens W.
        • van de Velde A.
        • et al.
        Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
        Clin Appl Thromb Hemost. 2006; 12: 277-295
        • Benson G.
        • Auerswald G.
        • Dolan G.
        • Duffy A.
        • Hermans C.
        • Ljung R.
        • et al.
        Diagnosis and care of patients with mild haemophilia: practical recommendations for clinical management.
        Blood Transfus. 2018; 16: 535-544
      1. Nutritional Anaemias [Internet].
        (Available at:)
        • Mannucci P.M.
        • Mauser-Bunschoten E.P.
        Cardiovascular disease in haemophilia patients: a contemporary issue.
        Haemophilia. 2010; 16: 58-66
        • Keeling D.
        • Tait C.
        • Makris M.
        Guideline on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders.
        Haemophilia. 2008; 14: 671-684
        • Heijdra J.M.
        • Cnossen M.H.
        • Leebeek F.W.G.
        Current and Emerging Options for the management of inherited von Willebrand disease.
        Drugs. 2017; 77: 1531-1547
        • Mannucci P.M.
        Treatment of von Willebrand’s disease.
        N Engl J Med. 2004; 351: 683-694
        • Fiore M.
        • Tuffigo M.
        • Cahoreau V.
        • Oses P.
        • Mouton C.
        Successful coronary artery bypass in types 2M and 2N von Willebrand disease.
        Ann Thorac Surg. 2016; 102: e423-e425
        • Nguyen T.
        • Hui S.K.
        • Soundar E.P.
        • Nguyen K.T.
        • Teruya M.
        • Cruz M.A.
        • et al.
        Abstract 452: loss of large von Willebrand factor multimers during pediatric extracorporeal membrane oxygenation support.
        Pediatr Crit Care Med. 2014; 15: 103-104
        • Jiritano F.
        • Cristodoro L.
        • Bevacqua E.
        • Malta E.
        • Mastroroberto P.
        An integrated approach to von Willebrand disease and surgical myocardial revascularization.
        Thorac Cardiovasc Surg Rep. 2015; 4: 37-39
        • Higgins R.A.
        • Goodwin A.J.
        Automated assays for von Willebrand factor activity.
        Am J Hematol. 2019; 94: 496-503
        • Srivastava A.
        • Santagostino E.
        • Dougall A.
        • Kitchen S.
        • Sutherland M.
        • Pipe S.
        • et al.
        WFH guidelines for the management of hemophilia, 3rd edition.
        Haemophilia. 2020; 26
        • Bhave P.
        • McGiffin D.
        • Shaw J.
        • Walsh M.
        • McCarthy P.
        • Tran H.
        • et al.
        Guide to performing cardiac surgery in patients with hereditary bleeding disorders.
        J Card Surg. 2015; 30: 61-69
        • Xu H.
        • Henry D.
        • Li C.
        • Zhao H.
        • Yang Y.
        Peri-cardiac surgery coagulation management in a severe hemophilia A patient.
        Medicine (Baltimore). 2019; 98
        • Menard C.E.
        • Zawadski D.
        • Singal R.K.
        • Rimmer E.
        • Houston D.S.
        • Houston B.L.
        • et al.
        Coronary artery bypass surgery in a patient with haemophilia A: a case report.
        Haemophilia. 2016; 22: e76-79
        • Suzuki T.
        • Kawamoto S.
        • Kumagai K.
        • Adachi O.
        • Kanda K.
        • Ishikawa M.
        • et al.
        Coronary artery bypass grafting in a patient with hemophilia B: continuous recombinant factor IX infusion as per the Japanese guidelines for replacement therapy.
        Gen Thorac Cardiovasc Surg. 2016; 64: 481-483
        • Topaloğlu U.S.
        • Özmen R.
        • Yüksel R.C.
        • Çetin M.
        • Akyol G.
        A successful coronary artery bypass operation with intermittent factor VIII administration in a hemophilia A patient who was admitted due to acute myocardial infarction: a rare and difficult case.
        Turk J Haematol. 2019; 36: 135-137
        • Bezaire J.
        • Thomson D.
        • McNair E.
        Recombinant factor VIII measurement in a hemophilia A patient undergoing cardiopulmonary bypass–supported cardiac surgery.
        J Extra Corpor Technol. 2018; 50: 170-177
        • Odonkor P.
        • Srinivas A.
        • Strauss E.
        • Williams B.
        • Mazzeffi M.
        • Tanaka K.A.
        Perioperative coagulation management of a hemophilia A patient during cardiac surgery.
        Semin Cardiothorac Vasc Anesth. 2017; 21: 312-320
        • Shalabi A.
        • Kachel E.
        • Kogan A.
        • Sternik L.
        • Grosman-Rimon L.
        • Ben-Avi R.
        • et al.
        Cardiac surgery in patients with Hemophilia:is it safe?.
        J Cardiothorac Surg. 2020; 15: 76
        • Loor G.
        • Rajeswaran J.
        • Li L.
        • Sabik J.F.
        • Blackstone E.H.
        • McCrae K.R.
        • et al.
        The least of 3 evils: exposure to red blood cell transfusion, anemia, or both?.
        J Thorac Cardiovasc Surg. 2013; 146: 1480-1487.e6
        • von Heymann C.
        • Kaufner L.
        • Sander M.
        • Spies C.
        • Schmidt K.
        • Gombotz H.
        • et al.
        Does the severity of preoperative anemia or blood transfusion have a stronger impact on long-term survival after cardiac surgery?.
        J Thorac Cardiovasc Surg. 2016; 152: 1412-1420
        • Gupta S.
        • Panchal P.
        • Gilotra K.
        • Wilfred A.M.
        • Hou W.
        • Siegal D.
        • et al.
        Intravenous iron therapy for patients with preoperative iron deficiency or anaemia undergoing cardiac surgery reduces blood transfusions: a systematic review and meta-analysis.
        Interact Cardiovasc Thorac Surg. 2020; 31: 141-151
        • Kei T.
        • Mistry N.
        • Curley G.
        • Pavenski K.
        • Shehata N.
        • Tanzini R.M.
        • et al.
        Efficacy and safety of erythropoietin and iron therapy to reduce red blood cell transfusion in surgical patients: a systematic review and meta-analysis.
        Can J Anaesth. 2019; 66: 716-731
        • NICE
        Blood transfusion NICE guideline [NG24] [Internet]. NICE.
        (Available at:)
        • Spahn D.R.
        • Schoenrath F.
        • Spahn G.H.
        • Seifert B.
        • Stein P.
        • Theusinger O.M.
        • et al.
        Effect of ultra-short-term treatment of patients with iron deficiency or anaemia undergoing cardiac surgery: a prospective randomised trial.
        Lancet. 2019; 393: 2201-2212
        • Gaudino M.
        • Angelini G.D.
        • Antoniades C.
        • Bakaeen F.
        • Benedetto U.
        • Calafiore A.M.
        • et al.
        Off-pump coronary artery bypass grafting: 30 years of debate.
        J Am Heart Assoc. 2018; 7: e009934
        • Stolla M.
        • Chang S.
        • Schulman S.
        • Bauer K.
        • Haspel R.
        • Lerner A.B.
        Use of thromboelastography in the management of a patient with acquired von Willebrand disease undergoing cardiac bypass surgery.
        Br J Haematol. 2018; 181: 143-145
        • Bolliger D.
        • Szlam F.
        • Azran M.
        • Koyama K.
        • Levy J.H.
        • Molinaro R.J.
        • et al.
        The anticoagulant effect of protamine sulfate is attenuated in the presence of platelets or elevated factor VIII concentrations.
        Anesth Analg. 2010; 111: 601-608
        • Park Y.S.
        • Shin W.-J.
        • Kim K.-I.
        Comparison of continuous infusion versus bolus injection of factor concentrates for blood management after total knee arthroplasty in patients with hemophilia.
        BMC Musculoskelet Disord. 2017; 18: 356
        • Lamy A.
        • Devereaux P.J.
        • Prabhakaran D.
        • Taggart D.P.
        • Hu S.
        • Paolasso E.
        • et al.
        Off-pump or on-pump coronary-artery bypass grafting at 30 days.
        N Engl J Med. 2012; 366: 1489-1497
        • Deppe A.-C.
        • Arbash W.
        • Kuhn E.W.
        • Slottosch I.
        • Scherner M.
        • Liakopoulos O.J.
        • et al.
        Current evidence of coronary artery bypass grafting off-pump versus on-pump: a systematic review with meta-analysis of over 16 900 patients investigated in randomized controlled trials.
        Eur J Cardiothorac Surg. 2016; 49: 1031-1041
        • Shander A.
        • Fink A.
        • Javidroozi M.
        • Erhard J.
        • Farmer S.L.
        • Corwin H.
        • et al.
        Appropriateness of allogeneic red blood cell transfusion: the international consensus conference on transfusion outcomes.
        Transfus Med Rev. 2011; 25: 232-246.e53
        • Shehata N.
        • Mistry N.
        • da Costa B.R.
        • Pereira T.V.
        • Whitlock R.
        • Curley G.F.
        • et al.
        Restrictive compared with liberal red cell transfusion strategies in cardiac surgery: a meta-analysis.
        Eur Heart J. 2019; 40: 1081-1088
        • Ferraris V.A.
        • Brown J.R.
        • Despotis G.J.
        • Hammon J.W.
        • Reece T.B.
        Society of Thoracic Surgeons Blood Conservation Guideline Task Force, et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines.
        Ann Thorac Surg. 2011; 91: 944-982
        • Wang G.
        • Xie G.
        • Jiang T.
        • Wang Y.
        • Wang W.
        • Ji H.
        • et al.
        Tranexamic acid reduces blood loss after off-pump coronary surgery: a prospective, randomized, double-blind, placebo-controlled study.
        Anesth Analg. 2012; 115: 239-243
        • Shi J.
        • Wang G.
        • Lv H.
        • Yuan S.
        • Wang Y.
        • Ji H.
        • et al.
        Tranexamic acid in on-pump coronary artery bypass grafting without clopidogrel and aspirin cessation: randomized trial and 1-year follow-up.
        Ann Thorac Surg. 2013; 95: 795-802
        • Ahn K.T.
        • Yamanaka K.
        • Iwakura A.
        • Hirose K.
        • Nakatsuka D.
        • Kusuhara T.
        • et al.
        Usefulness of intraoperative continuous infusion of tranexamic acid during emergency surgery for type A acute aortic dissection.
        Ann Thorac Cardiovasc Surg. 2014; 21: 66-71
        • Blaine K.P.
        • Press C.
        • Lau K.
        • Sliwa J.
        • Rao V.K.
        • Hill C.
        Comparative effectiveness of epsilon-aminocaproic acid and tranexamic acid on postoperative bleeding following cardiac surgery during a national medication shortage.
        J Clin Anesth. 2016; 35: 516-523
        • Anonymous
        European Medicines Agency recommends lifting suspension of aprotinin [Internet]. European Medicines Agency.
        (Available at:)
        • Meybohm P.
        • Choorapoikayil S.
        • Wessels A.
        • Herrmann E.
        • Zacharowski K.
        • Spahn D.R.
        Washed cell salvage in surgical patients: A review and meta-analysis of prospective randomized trials under PRISMA.
        Medicine (Baltimore). 2016; 95: e4490
        • Connell N.
        ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease. Am Soc Hematol [Internet].
        (Available at:)
        • Dunning J.
        • Versteegh M.
        • Fabbri A.
        • Pavie A.
        • Kolh P.
        • Lockowandt U.
        • et al.
        Guideline on antiplatelet and anticoagulation management in cardiac surgery.
        Eur J Cardiothorac Surg. 2008; 34: 73-92
        • Von Depka M.
        • Detering C.
        • Döpke S.
        • Ekhlasi-Hundrieser M.
        Management of perioperative anticoagulation in patients with VWD.
        Blood. 2015; 126: 1100
        • Martin K.
        • Key N.S.
        How I treat patients with inherited bleeding disorders who need anticoagulant therapy.
        Blood. 2016; 128: 178-184
        • Singh K.E.
        • Hirsch B.
        • Colquhoun D.
        • Durieux M.
        Fatal Intramyocardial Hemorrhage after pericardiotomy in a patient with von Willebrand disease.
        A A Case Rep. 2016; 7: 99-102
        • Batorova A.
        • Martinowitz U.
        Intermittent injections vs. continuous infusion of factor VIII in haemophilia patients undergoing major surgery.
        Br J Haematol. 2000; 110: 715-720
        • Johansson P.I.
        • Rasmussen A.S.
        • Thomsen L.L.
        Intravenous iron isomaltoside 1000 (Monofer®) reduces postoperative anaemia in preoperatively non-anaemic patients undergoing elective or subacute coronary artery bypass graft, valve replacement or a combination thereof: a randomized double-blind placebo-controlled clinical trial (the PROTECT trial).
        Vox Sang. 2015; 109: 257-266
        • Hogan M.
        • Klein A.A.
        • Richards T.
        The impact of anaemia and intravenous iron replacement therapy on outcomes in cardiac surgery.
        Eur J Cardiothorac Surg. 2015; 47: 218-226
        • Khalafallah A.A.
        • Yan C.
        • Al-Badri R.
        • Robinson E.
        • Kirkby B.E.
        • Ingram E.
        • et al.
        Intravenous ferric carboxymaltose versus standard care in the management of postoperative anaemia: a prospective, open-label, randomised controlled trial.
        Lancet Haematol. 2016; 3: e415-425
        • Sun X.
        • Hill P.C.
        • Taylor-PaneK S.L.
        • Corso P.J.
        • Lindsay J.
        Heparin-induced thrombocytopenia in contemporary cardiac surgical practice and experience with a protocol for early identification.
        Am J Cardiol. 2016; 117: 305-309